From 8^th-11^th of May we will join the Diabetes Congress DDG in Berlin to support rapid diffusion of acquired knowledge in the field of MASLD/MASH. Thus, we will present our discovery about the antifibrotic effects of our positive allosteric modulators of the GABA-A receptor including extended findings. We are looking forward to join interesting talks and discuss about the latest updates on drug development for MASLD and the comorbitidy diabetes. Do not hesitate to contact us and meet us there.